REVANCE THERAPEUTICS INC shareholders Q2 2023

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 15,833$400,7330.07%
NJ State Employees Deferred Compensation Plan 17,900$453,0490.06%
DRIEHAUS CAPITAL MANAGEMENT LLC 201,566$5,101,6350.06%
Caption Management, LLC 123,900$3,135,9090.06%
Engineers Gate Manager LP 56,045$1,418,4990.05%
TWO SIGMA INVESTMENTS, LP 816,839$20,674,1950.05%
D. E. Shaw & Co., Inc. 2,011,669$50,915,3430.05%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 431,096$10,911,0400.05%
Point72 Asset Management, L.P. 676,433$17,120,5190.05%
GREAT LAKES ADVISORS, LLC 195,290$4,942,7900.05%
Capital World Investors 9,574,874$242,340,0610.05%
BLAIR WILLIAM & CO/IL 496,275$12,560,7200.05%
Orbimed Advisors 100,000$2,531,0000.05%
Allspring Global Investments Holdings, LLC 1,131,361$28,634,7460.05%
Cubist Systematic Strategies, LLC 260,807$6,601,0250.04%
PUBLIC SECTOR PENSION INVESTMENT BOARD 254,000$6,428,7400.04%
NOTTINGHAM ADVISORS, INC. 11,979$303,1880.04%
CENTAURUS FINANCIAL, INC. 17,285$4370.04%
JENNISON ASSOCIATES LLC 1,839,267$46,551,8490.04%
Inspire Investing, LLC 12,441$314,8820.04%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.